If a waiver for electronic recordkeeping is granted, where should records for pseudoephedrine sales be submitted?

When a waiver for electronic recordkeeping is granted, records for pseudoephedrine sales should be submitted to the Office of the Attorney General. This is because the Attorney General's office is typically responsible for overseeing compliance with state laws regarding controlled substances, including pseudoephedrine, which is regulated due to its potential use in illicit drug manufacturing. By directing the records to this office, the regulatory framework ensures that all sales are properly monitored and controlled, allowing authorities to conduct necessary investigations and maintain public health and safety.

In the context of regulatory bodies, there could be specific guidelines that indicate which department oversees the documentation and enforcement of pseudoephedrine sales. This emphasizes the importance of reporting mechanisms to a centralized authority, which is in this case the Office of the Attorney General.